13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 64 holding rows worth $1,479,543,000.
- Accession
- 0001583977-19-000003
- Filer
- CIK 1583977
- Filed
- 2019-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, 64 entries on the cover page, a total value of $1,479,543,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,479,543,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Inflarx Nv | N44821101 | COM | 2,590,000 | $97,876,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 925,000 | $83,750,000 | thousands by filing date | put |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,075,000 | $78,798,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 600,000 | $70,620,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 3,600,000 | $70,200,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 920,000 | $67,206,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 1,100,000 | $56,617,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 615,000 | $52,564,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 1,411,898 | $48,005,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 4,600,000 | $41,446,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 1,009,586 | $38,990,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 450,000 | $36,023,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 300,000 | $35,757,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 2,525,900 | $35,085,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 300,000 | $34,965,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 275,000 | $34,331,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 900,000 | $32,148,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 600,000 | $31,194,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 1,272,495 | $30,477,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 750,000 | $30,375,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,700,000 | $29,818,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 850,000 | $26,750,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 450,000 | $24,755,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,400,000 | $23,226,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,300,000 | $23,062,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 550,000 | $21,863,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 130,000 | $20,677,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 715,482 | $18,753,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,271,687 | $17,231,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 500,000 | $16,800,000 | thousands by filing date | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 706,064 | $16,367,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 650,000 | $15,516,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 250,000 | $14,195,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 653,129 | $14,153,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 780,018 | $14,001,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 600,000 | $12,456,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 500,000 | $12,190,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 507,564 | $11,902,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 650,000 | $11,765,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 650,143 | $11,628,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 250,000 | $11,207,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 350,000 | $10,328,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 400,000 | $8,960,000 | thousands by filing date | |
| GENFIT S A | 372279109 | ADS | 350,000 | $8,400,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 839,642 | $7,985,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 90,000 | $7,929,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 300,000 | $6,615,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 673,891 | $6,382,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 270,000 | $4,876,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 607,903 | $4,778,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 454,549 | $4,632,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 252,749 | $4,400,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 100,000 | $3,902,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 150,000 | $3,666,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 178,891 | $3,361,000 | thousands by filing date | |
| ITERUM THERAPEUTICS PLC SHS NEW | G6333L101 | Stock | 398,300 | $3,198,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 200,000 | $3,028,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 400,000 | $2,944,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 30,000 | $2,580,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 420,555 | $2,519,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 250,000 | $2,300,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 40,000 | $1,863,000 | thousands by filing date | |
| OUTLOOK THERAPEUTICS INC | 69012T115 | *W EXP 02/18/202 | 416,666 | $150,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F120 | *W EXP 08/20/201 | 52,999 | $5,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-19-000003 | this filing | 2019-05-15 | acceptance time not in the bulk data set |